Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients von VONDERHEIDE, Robert H, DUTCHER, Janice P, GHALIE, Richard, CARON, Dania A, GRIBBEN, John G, ANDERSON, Jeanne E, ECKHARDT, S. Gail, STEPHANS, Katherine F, RAZVILLAS, Betty, GARL, Susan, BUTINE, Michael D, PERRY, Vicki P, ARMITAGE, Richard J

Volltext

Phase I and Pharmacokinetic Study of LU79553, a DNA Intercalating Bisnaphthalimide, in Patients With Solid Malignancies von VILLALONA-CALERO, Miguel A, EDER, Joseph P, KUFE, Donald W, VON HOFF, Daniel D, ROWINSKY, Eric K, TOPPMEYER, Deborah L, ALLEN, Lee F, FRAM, Robert, VELAGAPUDI, Raja, MYERS, Michael, AMATO, Anthony, KAGEN-HALLET, Kathleen, RAZVILLAS, Betty

Volltext

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies von VILLALONA-CALERO, M. A, BAKER, S. D, RAZVILLAS, B, JAKIMOWICZ, K, VON HOFF, D. D, ROWINSKY, E, HAMMOND, L, AYLESWORTH, C, ECKHARDT, S. G, KRAYNAK, M, FRAM, R, FISCHKOFF, S, VELAGAPUDI, R, TOPPMEYER, D

Volltext

Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis von Anderson, Jeanne E., Tefferi, Ayalew, Craig, Fiona, Holmberg, Leona, Chauncey, Thomas, Appelbaum, Frederick R., Guardiola, Philippe, Callander, Natalie, Freytes, Cesar, Gazitt, Yair, Razvillas, Betty, Deeg, H. Joachim

Volltext

Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer von SHARMAL, J. J, RAZVILLAS, B, STEPHENS, C. D, HILSENBECK, S. G, SHARMA, A, ROTHENBERG, M. L

Volltext